Sanofi: US FDA approves Sanofi's Qfitlia to treat haemophilia A or B, with or without factor inhibitors

The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and paediatric patients 12 years of age and older with